The effects of cannabidiol on impulsivity and memory during abstinence in cigarette dependent smokers /631/154/53 /631/378/1595/1636 /631/477/2811 article

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Hindocha, C ^a   Freeman, T P ^a,b   Grabski, M ^a,c   Crudgington, H ^a   Davies, A C ^a   Stroud, J B ^e   Das, R K ^a   Lawn, W ^a   Morgan, C J A ^a,d   Curran, H V ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF EXETER   (United Kingdom)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIDIOL;

ADULT; BAYES THEOREM; DRUG EFFECT; FEMALE; HUMAN; IMPULSIVENESS; MALE; MEMORY; PSYCHOLOGY; RANDOMIZATION; SHORT TERM MEMORY; SPATIAL MEMORY; TOBACCO DEPENDENCE; YOUNG ADULT;

ADULT; BAYES THEOREM; CANNABIDIOL; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MEMORY; MEMORY, SHORT-TERM; RANDOM ALLOCATION; SPATIAL MEMORY; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 85047097789     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-25846-2     Document Type: Article

References (47)

1. Brown, J. et al. Cigarette craving and withdrawal symptoms during temporary abstinence and the effect of nicotine gum. Psychopharmacology (Berl.) 229, 209-218 (2013).
2. Hughes, J. R. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine & Tobacco Research 9, 315-327 (2007).
3. Shiffman, S. et al. Immediate antecedents of cigarette smoking: an analysis from ecological momentary assessment. J. Abnorm. Psychol. 111, 531 (2002).
4. Grabski, M. et al. Behavioral tasks sensitive to acute abstinence and predictive of smoking cessation success: A systematic review and meta?analysis. Addiction 111, 2134-2144, https://doi.org/10.1111/add.13507 (2016).
5. Bickel, W. K., Johnson, M. W., Koffarnus, M. N., MacKillop, J. & Murphy, J. G. The behavioral economics of substance use disorders: reinforcement pathologies and their repair. Annu. Rev. Clin. Psychol. 10, 641 (2014).
6. De Wit, H. Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict. Biol. 14, 22-31 (2009).
7. Mendrek, A. et al. Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence. Addict. Behav. 31, 833-844, https://doi.org/10.1016/j.addbeh.2005.06.009 (2006).
8. Xu, J. et al. Brain Activity in Cigarette Smokers Performing a Working Memory Task: Effect of Smoking Abstinence. Biological psychiatry 58, 143-150, https://doi.org/10.1016/j.biopsych.2005.03.028 (2005).
9. Hindocha, C. et al. Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal. Addiction https://doi.org/10.1111/add.14243 (2018).
10. Ren, Y., Whittard, J., Higuera-Matas, A., Morris, C. V. & Hurd, Y. L. Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances. The Journal of Neuroscience 29, 14764-14769 (2009).
11. Hurd, Y. L. et al. Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage. Neurotherapeutics 12, 807-815, https://doi.org/10.1007/s13311-015-0373-7 (2015).
12. Morgan, C. J., Das, R. K., Joye, A., Curran, H. V. & Kamboj, S. K. Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings. Addict. Behav. 38, 2433-2436 (2013).
13. Englund, A. et al. Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. Journal of Psychopharmacology 27, 19-27 (2013).
14. Morgan, C. J., Schafer, G., Freeman, T. P. & Curran, H. V. Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected]. Br. J. Psychiatry 197, 285-290, https://doi.org/10.1192/bjp. bp.110.077503 (2010).
15. Morgan, C. et al. Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being. Psychol. Med. 42, 391-400 (2012).
16. Osborne, A. L., Solowij, N. & Weston-Green, K. A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia. Neurosci. Biobehav. Rev. 72, 310-324, https://doi.org/10.1016/j.neubiorev.2016.11.012 (2017).
17. Bhattacharyya, S. et al. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology 35, 764-774, https://doi.org/10.1038/npp.2009.184 (2010).
18. Borgwardt, S. J. et al. Neural basis of ?-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biological psychiatry 64, 966-973 (2008).
19. Lerman, C. et al. Translational research in medication development for nicotine dependence. Nat Rev Drug Discov 6, 746-762, https://doi.org/10.1038/nrd2361 (2007).
20. Billieux, J. et al. Lack of inhibitory control predicts cigarette smoking dependence: evidence from a non-deprived sample of light to moderate smokers. Drug Alcohol Depend 112, 164-167, https://doi.org/10.1016/j.drugalcdep.2010.06.006 (2010).
21. Powell, J., Dawkins, L. & Davis, R. E. Smoking, reward responsiveness, and response inhibition: tests of an incentive motivational model. Biol Psychiatry 51, 151-163 (2002).
22. Powell, J., Dawkins, L., West, R., Powell, J. & Pickering, A. Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors. Psychopharmacology (Berl.) 212, 537-549 (2010).
23. Hundal, H. et al. The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group. Journal of Psychopharmacology, 1-7, https://doi.org/10.1177/0269881117737400 (2017).
24. Morgan, C. J., Freeman, T. P., Schafer, G. L. & Curran, H. V. Cannabidiol attenuates the appetitive effects of ?9-tetrahydrocannabinol in humans smoking their chosen cannabis. Neuropsychopharmacology 35, 1879-1885 (2010).
25. Zuardi, A. W. et al. Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in RealLife. Front. Pharmacol. 8, 259, https://doi.org/10.3389/fphar.2017.00259 (2017).
26. Babalonis, S. et al. Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers. Drug Alcohol Depend. 172, 9-13, https://doi.org/10.1016/j.drugalcdep.2016.11.030 (2016).
27. Benowitz, N. L. et al. Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research 4, 149-159 (2002).
28. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C. & Fagerstrom, K. O. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br. J. Addict. 86, 1119-1127 (1991).
29. Button, K. S. et al. Power failure: why small sample size undermines the reliability of neuroscience. Nature Reviews Neuroscience 14, 365-376 (2013).
30. Leweke, F. et al. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Translational psychiatry 2, e94 (2012).
31. Haney, M. et al. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis. Neuropsychopharmacology 41, 1974-1982, https://doi.org/10.1038/npp.2015.367 (2015).
32. Manini, A. F. et al. Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humans. J. Addict. Med. 9, 204-210, https://doi.org/10.1097/ADM.0000000000000118 (2015).
33. Bhattacharyya, S. et al. Cannabinoid modulation of functional connectivity within regions processing attentional salience. Neuropsychopharmacology 40, 1343-1352, https://doi.org/10.1038/npp.2014.258 (2015).
34. Solowij, N., Broyd, S. J., van Hell, H. H. & Hazekamp, A. A protocol for the delivery of cannabidiol (CBD) and combined CBD and ?(9)-tetrahydrocannabinol (THC) by vaporisation. BMC Pharmacology & Toxicology 15, 58, https://doi.org/10.1186/2050-6511-15-58 (2014).
35. Field, M., Santarcangelo, M., Sumnall, H., Goudie, A. & Cole, J. Delay discounting and the behavioural economics of cigarette purchases in smokers: the effects of nicotine deprivation. Psychopharmacology (Berl.) 186, 255-263 (2006).
36. Reed, D. D., Kaplan, B. A. & Brewer, A. T. A tutorial on the use of excel 2010 and excel for mac 2011 for conducting delay-discounting analyses. J. Appl. Behav. Anal. 45, 375-386, https://doi.org/10.1901/jaba.2012.45-375 (2012).
37. Logan, G. D., Schachar, R. J. & Tannock, R. Impulsivity and inhibitory control. Psychol. Sci. 8, 60-64 (1997).
38. Wilson, B. A., Cockburn, J. & Baddeley, A. D. The Rivermead behavioural memory test (Thames Valley Test Company, 1991).
39. Hindocha, C., Freeman, T. P., Xia, J. X., Shaban, N. D. C. & Curran, H. V. Acute memory and psychotomimetic effects of cannabis and tobacco both 'joint' and individually: a placebo-controlled trial. Psychol. Med. 47, 2708-2719, https://doi.org/10.1017/ S0033291717001222 (2017).
40. Freeman, T. P. et al. Cognitive and subjective effects of mephedrone and factors influencing use of a 'new legal high'. Addiction 107, 792-800 (2012).
41. Toll, B. A., Katulak, N. A. & McKee, S. A. Investigating the factor structure of the Questionnaire on Smoking Urges-Brief (QSUBrief). Addict. Behav. 31, 1231-1239 (2006).
42. West, R. & Hajek, P. Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology (Berl.) 177, 195-199 (2004).
43. Kraemer, H. A source of false findings in published research studies: Adjusting for covariates. JAMA Psychiatry 72, 961-962, https:// doi.org/10.1001/jamapsychiatry.2015.1178 (2015).
44. Buckingham, J. et al. A Moderate Dose of Alcohol Does Not Influence Experience of Social Ostracism in Hazardous Drinkers. Front. Psychol. 7, 555, https://doi.org/10.3389/fpsyg.2016.00555 (2016).
45. Lawn, W. et al. The acute effects of a dopamine D3 receptor preferring agonist on motivation for cigarettes in dependent and occasional cigarette smokers. Nicotine & Tobacco Research ntx159, https://doi.org/10.1093/ntr/ntx159 (2017).
46. Rouder, J. N., Speckman, P. L., Sun, D., Morey, R. D. & Iverson, G. Bayesian t tests for accepting and rejecting the null hypothesis. Psychonomic bulletin & review 16, 225-237 (2009).
47. Jarosz, A. F. & Wiley, J. What are the odds? A practical guide to computing and reporting Bayes factors. The Journal of Problem Solving 7, 2 (2014).